nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Leflunomide—systemic scleroderma	0.143	0.243	CbGbCtD
Venlafaxine—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0886	0.15	CbGbCtD
Venlafaxine—ABCB1—Lisinopril—systemic scleroderma	0.0542	0.0918	CbGbCtD
Venlafaxine—CYP2C9—Leflunomide—systemic scleroderma	0.0533	0.0903	CbGbCtD
Venlafaxine—ABCB1—Captopril—systemic scleroderma	0.0406	0.0687	CbGbCtD
Venlafaxine—CYP2D6—Captopril—systemic scleroderma	0.0382	0.0648	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—systemic scleroderma	0.0355	0.0602	CbGbCtD
Venlafaxine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0319	0.0541	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—systemic scleroderma	0.0317	0.0536	CbGbCtD
Venlafaxine—ABCB1—Prednisone—systemic scleroderma	0.0255	0.0433	CbGbCtD
Venlafaxine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0191	0.0324	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—systemic scleroderma	0.0153	0.0259	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—systemic scleroderma	0.0128	0.0217	CbGbCtD
Venlafaxine—CYP2C9—cardial valve—systemic scleroderma	0.00228	0.548	CbGeAlD
Venlafaxine—NPY1R—lung—systemic scleroderma	0.000333	0.0799	CbGeAlD
Venlafaxine—SLC6A4—digestive system—systemic scleroderma	0.000154	0.0369	CbGeAlD
Venlafaxine—ABCB1—blood vessel—systemic scleroderma	0.000144	0.0346	CbGeAlD
Venlafaxine—SLC6A3—lung—systemic scleroderma	0.00014	0.0336	CbGeAlD
Venlafaxine—SLC6A4—lung—systemic scleroderma	0.000128	0.0308	CbGeAlD
Venlafaxine—CYP2C19—digestive system—systemic scleroderma	0.000127	0.0306	CbGeAlD
Venlafaxine—CYP2B6—skin of body—systemic scleroderma	0.000125	0.0299	CbGeAlD
Venlafaxine—SLC6A2—lung—systemic scleroderma	0.000113	0.0271	CbGeAlD
Venlafaxine—Weight increased—Prednisone—systemic scleroderma	0.000112	0.000277	CcSEcCtD
Venlafaxine—Ataxia—Methotrexate—systemic scleroderma	0.000112	0.000277	CcSEcCtD
Venlafaxine—Constipation—Mycophenolic acid—systemic scleroderma	0.000112	0.000276	CcSEcCtD
Venlafaxine—Pain—Mycophenolic acid—systemic scleroderma	0.000112	0.000276	CcSEcCtD
Venlafaxine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000276	CcSEcCtD
Venlafaxine—Weight decreased—Prednisone—systemic scleroderma	0.000112	0.000275	CcSEcCtD
Venlafaxine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000275	CcSEcCtD
Venlafaxine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000111	0.000274	CcSEcCtD
Venlafaxine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000273	CcSEcCtD
Venlafaxine—Hypotension—Lisinopril—systemic scleroderma	0.00011	0.000272	CcSEcCtD
Venlafaxine—Dizziness—Captopril—systemic scleroderma	0.00011	0.000272	CcSEcCtD
Venlafaxine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00011	0.000272	CcSEcCtD
Venlafaxine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000271	CcSEcCtD
Venlafaxine—Depression—Prednisone—systemic scleroderma	0.00011	0.00027	CcSEcCtD
Venlafaxine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00027	CcSEcCtD
Venlafaxine—Urticaria—Leflunomide—systemic scleroderma	0.000109	0.000269	CcSEcCtD
Venlafaxine—Body temperature increased—Leflunomide—systemic scleroderma	0.000109	0.000268	CcSEcCtD
Venlafaxine—Abdominal pain—Leflunomide—systemic scleroderma	0.000109	0.000268	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000108	0.000267	CcSEcCtD
Venlafaxine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Myocardial infarction—Prednisone—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000108	0.000266	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000108	0.000265	CcSEcCtD
Venlafaxine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000265	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000107	0.000265	CcSEcCtD
Venlafaxine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000107	0.000264	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000107	0.000264	CcSEcCtD
Venlafaxine—Insomnia—Lisinopril—systemic scleroderma	0.000107	0.000263	CcSEcCtD
Venlafaxine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000263	CcSEcCtD
Venlafaxine—Paraesthesia—Lisinopril—systemic scleroderma	0.000106	0.000262	CcSEcCtD
Venlafaxine—Vomiting—Captopril—systemic scleroderma	0.000106	0.000261	CcSEcCtD
Venlafaxine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000106	0.00026	CcSEcCtD
Venlafaxine—Dyspnoea—Lisinopril—systemic scleroderma	0.000105	0.00026	CcSEcCtD
Venlafaxine—Rash—Captopril—systemic scleroderma	0.000105	0.000259	CcSEcCtD
Venlafaxine—Dermatitis—Captopril—systemic scleroderma	0.000105	0.000259	CcSEcCtD
Venlafaxine—Somnolence—Lisinopril—systemic scleroderma	0.000105	0.000259	CcSEcCtD
Venlafaxine—Headache—Captopril—systemic scleroderma	0.000104	0.000258	CcSEcCtD
Venlafaxine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000257	CcSEcCtD
Venlafaxine—Dyspepsia—Lisinopril—systemic scleroderma	0.000104	0.000256	CcSEcCtD
Venlafaxine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000104	0.000256	CcSEcCtD
Venlafaxine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000104	0.000256	CcSEcCtD
Venlafaxine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000255	CcSEcCtD
Venlafaxine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000255	CcSEcCtD
Venlafaxine—Asthma—Methotrexate—systemic scleroderma	0.000103	0.000254	CcSEcCtD
Venlafaxine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000254	CcSEcCtD
Venlafaxine—Decreased appetite—Lisinopril—systemic scleroderma	0.000103	0.000253	CcSEcCtD
Venlafaxine—Eosinophilia—Methotrexate—systemic scleroderma	0.000102	0.000252	CcSEcCtD
Venlafaxine—Fatigue—Lisinopril—systemic scleroderma	0.000102	0.000251	CcSEcCtD
Venlafaxine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000251	CcSEcCtD
Venlafaxine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.00025	CcSEcCtD
Venlafaxine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000101	0.00025	CcSEcCtD
Venlafaxine—Pancreatitis—Methotrexate—systemic scleroderma	0.000101	0.000249	CcSEcCtD
Venlafaxine—Constipation—Lisinopril—systemic scleroderma	0.000101	0.000249	CcSEcCtD
Venlafaxine—Pain—Lisinopril—systemic scleroderma	0.000101	0.000249	CcSEcCtD
Venlafaxine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000249	CcSEcCtD
Venlafaxine—Bradycardia—Prednisone—systemic scleroderma	0.000101	0.000248	CcSEcCtD
Venlafaxine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000247	CcSEcCtD
Venlafaxine—CYP2B6—digestive system—systemic scleroderma	9.97e-05	0.0239	CbGeAlD
Venlafaxine—Diarrhoea—Azathioprine—systemic scleroderma	9.96e-05	0.000246	CcSEcCtD
Venlafaxine—Haemoglobin—Prednisone—systemic scleroderma	9.92e-05	0.000245	CcSEcCtD
Venlafaxine—Nausea—Captopril—systemic scleroderma	9.91e-05	0.000244	CcSEcCtD
Venlafaxine—Haemorrhage—Prednisone—systemic scleroderma	9.87e-05	0.000243	CcSEcCtD
Venlafaxine—CYP2C9—digestive system—systemic scleroderma	9.87e-05	0.0237	CbGeAlD
Venlafaxine—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.86e-05	0.000243	CcSEcCtD
Venlafaxine—Asthenia—Leflunomide—systemic scleroderma	9.86e-05	0.000243	CcSEcCtD
Venlafaxine—Hallucination—Prednisone—systemic scleroderma	9.82e-05	0.000242	CcSEcCtD
Venlafaxine—Pancytopenia—Methotrexate—systemic scleroderma	9.79e-05	0.000241	CcSEcCtD
Venlafaxine—Feeling abnormal—Lisinopril—systemic scleroderma	9.73e-05	0.00024	CcSEcCtD
Venlafaxine—Pruritus—Leflunomide—systemic scleroderma	9.72e-05	0.00024	CcSEcCtD
Venlafaxine—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.67e-05	0.000238	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.66e-05	0.000238	CcSEcCtD
Venlafaxine—Dysuria—Methotrexate—systemic scleroderma	9.64e-05	0.000238	CcSEcCtD
Venlafaxine—Neutropenia—Methotrexate—systemic scleroderma	9.64e-05	0.000238	CcSEcCtD
Venlafaxine—Dizziness—Azathioprine—systemic scleroderma	9.63e-05	0.000237	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	9.58e-05	0.000236	CcSEcCtD
Venlafaxine—Erectile dysfunction—Methotrexate—systemic scleroderma	9.49e-05	0.000234	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000232	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Methotrexate—systemic scleroderma	9.41e-05	0.000232	CcSEcCtD
Venlafaxine—Asthenia—Mycophenolic acid—systemic scleroderma	9.41e-05	0.000232	CcSEcCtD
Venlafaxine—Diarrhoea—Leflunomide—systemic scleroderma	9.4e-05	0.000232	CcSEcCtD
Venlafaxine—Urticaria—Lisinopril—systemic scleroderma	9.38e-05	0.000231	CcSEcCtD
Venlafaxine—Insomnia—Mycophenolate mofetil—systemic scleroderma	9.36e-05	0.000231	CcSEcCtD
Venlafaxine—Body temperature increased—Lisinopril—systemic scleroderma	9.34e-05	0.00023	CcSEcCtD
Venlafaxine—Abdominal pain—Lisinopril—systemic scleroderma	9.34e-05	0.00023	CcSEcCtD
Venlafaxine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	9.29e-05	0.000229	CcSEcCtD
Venlafaxine—Pruritus—Mycophenolic acid—systemic scleroderma	9.28e-05	0.000229	CcSEcCtD
Venlafaxine—Vomiting—Azathioprine—systemic scleroderma	9.25e-05	0.000228	CcSEcCtD
Venlafaxine—Pneumonia—Methotrexate—systemic scleroderma	9.25e-05	0.000228	CcSEcCtD
Venlafaxine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	9.23e-05	0.000227	CcSEcCtD
Venlafaxine—Somnolence—Mycophenolate mofetil—systemic scleroderma	9.2e-05	0.000227	CcSEcCtD
Venlafaxine—Rash—Azathioprine—systemic scleroderma	9.18e-05	0.000226	CcSEcCtD
Venlafaxine—Dermatitis—Azathioprine—systemic scleroderma	9.17e-05	0.000226	CcSEcCtD
Venlafaxine—Depression—Methotrexate—systemic scleroderma	9.17e-05	0.000226	CcSEcCtD
Venlafaxine—Flushing—Prednisone—systemic scleroderma	9.16e-05	0.000226	CcSEcCtD
Venlafaxine—Headache—Azathioprine—systemic scleroderma	9.12e-05	0.000225	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	9.11e-05	0.000225	CcSEcCtD
Venlafaxine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	9.11e-05	0.000225	CcSEcCtD
Venlafaxine—Dizziness—Leflunomide—systemic scleroderma	9.09e-05	0.000224	CcSEcCtD
Venlafaxine—Renal failure—Methotrexate—systemic scleroderma	9.04e-05	0.000223	CcSEcCtD
Venlafaxine—ABCG2—lung—systemic scleroderma	9.02e-05	0.0217	CbGeAlD
Venlafaxine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	9e-05	0.000222	CcSEcCtD
Venlafaxine—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.97e-05	0.000221	CcSEcCtD
Venlafaxine—Stomatitis—Methotrexate—systemic scleroderma	8.96e-05	0.000221	CcSEcCtD
Venlafaxine—Conjunctivitis—Methotrexate—systemic scleroderma	8.93e-05	0.00022	CcSEcCtD
Venlafaxine—Constipation—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.000218	CcSEcCtD
Venlafaxine—Pain—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.000218	CcSEcCtD
Venlafaxine—Arrhythmia—Prednisone—systemic scleroderma	8.82e-05	0.000217	CcSEcCtD
Venlafaxine—Sweating—Methotrexate—systemic scleroderma	8.81e-05	0.000217	CcSEcCtD
Venlafaxine—Haematuria—Methotrexate—systemic scleroderma	8.76e-05	0.000216	CcSEcCtD
Venlafaxine—Vomiting—Leflunomide—systemic scleroderma	8.74e-05	0.000215	CcSEcCtD
Venlafaxine—Alopecia—Prednisone—systemic scleroderma	8.72e-05	0.000215	CcSEcCtD
Venlafaxine—Hypersensitivity—Lisinopril—systemic scleroderma	8.7e-05	0.000215	CcSEcCtD
Venlafaxine—Dizziness—Mycophenolic acid—systemic scleroderma	8.67e-05	0.000214	CcSEcCtD
Venlafaxine—Epistaxis—Methotrexate—systemic scleroderma	8.67e-05	0.000214	CcSEcCtD
Venlafaxine—Rash—Leflunomide—systemic scleroderma	8.67e-05	0.000214	CcSEcCtD
Venlafaxine—Dermatitis—Leflunomide—systemic scleroderma	8.66e-05	0.000214	CcSEcCtD
Venlafaxine—Nausea—Azathioprine—systemic scleroderma	8.65e-05	0.000213	CcSEcCtD
Venlafaxine—Headache—Leflunomide—systemic scleroderma	8.61e-05	0.000212	CcSEcCtD
Venlafaxine—Erythema—Prednisone—systemic scleroderma	8.6e-05	0.000212	CcSEcCtD
Venlafaxine—Agranulocytosis—Methotrexate—systemic scleroderma	8.58e-05	0.000212	CcSEcCtD
Venlafaxine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	8.53e-05	0.00021	CcSEcCtD
Venlafaxine—Asthenia—Lisinopril—systemic scleroderma	8.47e-05	0.000209	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.000209	CcSEcCtD
Venlafaxine—Pruritus—Lisinopril—systemic scleroderma	8.36e-05	0.000206	CcSEcCtD
Venlafaxine—Vomiting—Mycophenolic acid—systemic scleroderma	8.34e-05	0.000206	CcSEcCtD
Venlafaxine—CYP2B6—lung—systemic scleroderma	8.32e-05	0.02	CbGeAlD
Venlafaxine—Haemoglobin—Methotrexate—systemic scleroderma	8.29e-05	0.000204	CcSEcCtD
Venlafaxine—Rash—Mycophenolic acid—systemic scleroderma	8.27e-05	0.000204	CcSEcCtD
Venlafaxine—Dermatitis—Mycophenolic acid—systemic scleroderma	8.26e-05	0.000204	CcSEcCtD
Venlafaxine—Haemorrhage—Methotrexate—systemic scleroderma	8.25e-05	0.000203	CcSEcCtD
Venlafaxine—Hepatitis—Methotrexate—systemic scleroderma	8.25e-05	0.000203	CcSEcCtD
Venlafaxine—Urticaria—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.000203	CcSEcCtD
Venlafaxine—Headache—Mycophenolic acid—systemic scleroderma	8.21e-05	0.000203	CcSEcCtD
Venlafaxine—Pharyngitis—Methotrexate—systemic scleroderma	8.19e-05	0.000202	CcSEcCtD
Venlafaxine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	8.18e-05	0.000202	CcSEcCtD
Venlafaxine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	8.18e-05	0.000202	CcSEcCtD
Venlafaxine—Nausea—Leflunomide—systemic scleroderma	8.16e-05	0.000201	CcSEcCtD
Venlafaxine—Vision blurred—Prednisone—systemic scleroderma	8.1e-05	0.0002	CcSEcCtD
Venlafaxine—Diarrhoea—Lisinopril—systemic scleroderma	8.08e-05	0.000199	CcSEcCtD
Venlafaxine—Ill-defined disorder—Prednisone—systemic scleroderma	7.97e-05	0.000197	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—systemic scleroderma	7.95e-05	0.000196	CcSEcCtD
Venlafaxine—Anaemia—Prednisone—systemic scleroderma	7.94e-05	0.000196	CcSEcCtD
Venlafaxine—Agitation—Prednisone—systemic scleroderma	7.9e-05	0.000195	CcSEcCtD
Venlafaxine—Angioedema—Prednisone—systemic scleroderma	7.85e-05	0.000194	CcSEcCtD
Venlafaxine—Dizziness—Lisinopril—systemic scleroderma	7.81e-05	0.000193	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—systemic scleroderma	7.8e-05	0.000192	CcSEcCtD
Venlafaxine—Nausea—Mycophenolic acid—systemic scleroderma	7.79e-05	0.000192	CcSEcCtD
Venlafaxine—Malaise—Prednisone—systemic scleroderma	7.75e-05	0.000191	CcSEcCtD
Venlafaxine—Vertigo—Prednisone—systemic scleroderma	7.72e-05	0.00019	CcSEcCtD
Venlafaxine—Syncope—Prednisone—systemic scleroderma	7.71e-05	0.00019	CcSEcCtD
Venlafaxine—Tinnitus—Methotrexate—systemic scleroderma	7.69e-05	0.00019	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—systemic scleroderma	7.66e-05	0.000189	CcSEcCtD
Venlafaxine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.62e-05	0.000188	CcSEcCtD
Venlafaxine—Loss of consciousness—Prednisone—systemic scleroderma	7.55e-05	0.000186	CcSEcCtD
Venlafaxine—CYP3A4—digestive system—systemic scleroderma	7.53e-05	0.0181	CbGeAlD
Venlafaxine—Vomiting—Lisinopril—systemic scleroderma	7.51e-05	0.000185	CcSEcCtD
Venlafaxine—Rash—Lisinopril—systemic scleroderma	7.45e-05	0.000184	CcSEcCtD
Venlafaxine—Convulsion—Prednisone—systemic scleroderma	7.45e-05	0.000184	CcSEcCtD
Venlafaxine—Dermatitis—Lisinopril—systemic scleroderma	7.44e-05	0.000183	CcSEcCtD
Venlafaxine—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.42e-05	0.000183	CcSEcCtD
Venlafaxine—Hypertension—Prednisone—systemic scleroderma	7.42e-05	0.000183	CcSEcCtD
Venlafaxine—CYP2D6—digestive system—systemic scleroderma	7.41e-05	0.0178	CbGeAlD
Venlafaxine—Chills—Methotrexate—systemic scleroderma	7.4e-05	0.000183	CcSEcCtD
Venlafaxine—Headache—Lisinopril—systemic scleroderma	7.4e-05	0.000182	CcSEcCtD
Venlafaxine—Pruritus—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.000181	CcSEcCtD
Venlafaxine—Arthralgia—Prednisone—systemic scleroderma	7.32e-05	0.00018	CcSEcCtD
Venlafaxine—Myalgia—Prednisone—systemic scleroderma	7.32e-05	0.00018	CcSEcCtD
Venlafaxine—Anxiety—Prednisone—systemic scleroderma	7.29e-05	0.00018	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—systemic scleroderma	7.29e-05	0.00018	CcSEcCtD
Venlafaxine—Discomfort—Prednisone—systemic scleroderma	7.23e-05	0.000178	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—systemic scleroderma	7.18e-05	0.000177	CcSEcCtD
Venlafaxine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	7.08e-05	0.000175	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—systemic scleroderma	7.03e-05	0.000173	CcSEcCtD
Venlafaxine—Nausea—Lisinopril—systemic scleroderma	7.02e-05	0.000173	CcSEcCtD
Venlafaxine—Oedema—Prednisone—systemic scleroderma	7.01e-05	0.000173	CcSEcCtD
Venlafaxine—Anaphylactic shock—Prednisone—systemic scleroderma	7.01e-05	0.000173	CcSEcCtD
Venlafaxine—Infection—Prednisone—systemic scleroderma	6.97e-05	0.000172	CcSEcCtD
Venlafaxine—Back pain—Methotrexate—systemic scleroderma	6.95e-05	0.000171	CcSEcCtD
Venlafaxine—Shock—Prednisone—systemic scleroderma	6.9e-05	0.00017	CcSEcCtD
Venlafaxine—Tachycardia—Prednisone—systemic scleroderma	6.85e-05	0.000169	CcSEcCtD
Venlafaxine—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.84e-05	0.000169	CcSEcCtD
Venlafaxine—Hyperhidrosis—Prednisone—systemic scleroderma	6.78e-05	0.000167	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—systemic scleroderma	6.77e-05	0.000167	CcSEcCtD
Venlafaxine—Anorexia—Prednisone—systemic scleroderma	6.69e-05	0.000165	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—systemic scleroderma	6.66e-05	0.000164	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—systemic scleroderma	6.64e-05	0.000164	CcSEcCtD
Venlafaxine—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.000162	CcSEcCtD
Venlafaxine—Rash—Mycophenolate mofetil—systemic scleroderma	6.52e-05	0.000161	CcSEcCtD
Venlafaxine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.52e-05	0.000161	CcSEcCtD
Venlafaxine—Headache—Mycophenolate mofetil—systemic scleroderma	6.48e-05	0.00016	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—systemic scleroderma	6.48e-05	0.00016	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—systemic scleroderma	6.45e-05	0.000159	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—systemic scleroderma	6.43e-05	0.000159	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	6.39e-05	0.000158	CcSEcCtD
Venlafaxine—Insomnia—Prednisone—systemic scleroderma	6.34e-05	0.000156	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisone—systemic scleroderma	6.3e-05	0.000155	CcSEcCtD
Venlafaxine—Cough—Methotrexate—systemic scleroderma	6.27e-05	0.000155	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—systemic scleroderma	6.22e-05	0.000153	CcSEcCtD
Venlafaxine—Dyspepsia—Prednisone—systemic scleroderma	6.17e-05	0.000152	CcSEcCtD
Venlafaxine—Nausea—Mycophenolate mofetil—systemic scleroderma	6.15e-05	0.000152	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—systemic scleroderma	6.12e-05	0.000151	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—systemic scleroderma	6.12e-05	0.000151	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—systemic scleroderma	6.12e-05	0.000151	CcSEcCtD
Venlafaxine—Decreased appetite—Prednisone—systemic scleroderma	6.1e-05	0.00015	CcSEcCtD
Venlafaxine—Fatigue—Prednisone—systemic scleroderma	6.05e-05	0.000149	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—systemic scleroderma	6.04e-05	0.000149	CcSEcCtD
Venlafaxine—Constipation—Prednisone—systemic scleroderma	6e-05	0.000148	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—systemic scleroderma	5.91e-05	0.000146	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—systemic scleroderma	5.86e-05	0.000145	CcSEcCtD
Venlafaxine—Infection—Methotrexate—systemic scleroderma	5.82e-05	0.000144	CcSEcCtD
Venlafaxine—Feeling abnormal—Prednisone—systemic scleroderma	5.78e-05	0.000143	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—systemic scleroderma	5.74e-05	0.000142	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Prednisone—systemic scleroderma	5.74e-05	0.000141	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—systemic scleroderma	5.67e-05	0.00014	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—systemic scleroderma	5.59e-05	0.000138	CcSEcCtD
Venlafaxine—Urticaria—Prednisone—systemic scleroderma	5.57e-05	0.000137	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—systemic scleroderma	5.55e-05	0.000137	CcSEcCtD
Venlafaxine—Body temperature increased—Prednisone—systemic scleroderma	5.55e-05	0.000137	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—systemic scleroderma	5.48e-05	0.000135	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.34e-05	0.000132	CcSEcCtD
Venlafaxine—ABCB1—digestive system—systemic scleroderma	5.33e-05	0.0128	CbGeAlD
Venlafaxine—Insomnia—Methotrexate—systemic scleroderma	5.3e-05	0.000131	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—systemic scleroderma	5.26e-05	0.00013	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—systemic scleroderma	5.23e-05	0.000129	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—systemic scleroderma	5.21e-05	0.000129	CcSEcCtD
Venlafaxine—Hypersensitivity—Prednisone—systemic scleroderma	5.17e-05	0.000127	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—systemic scleroderma	5.16e-05	0.000127	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—systemic scleroderma	5.1e-05	0.000126	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—systemic scleroderma	5.05e-05	0.000125	CcSEcCtD
Venlafaxine—Asthenia—Prednisone—systemic scleroderma	5.03e-05	0.000124	CcSEcCtD
Venlafaxine—Pain—Methotrexate—systemic scleroderma	5.01e-05	0.000124	CcSEcCtD
Venlafaxine—Pruritus—Prednisone—systemic scleroderma	4.96e-05	0.000122	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—systemic scleroderma	4.83e-05	0.000119	CcSEcCtD
Venlafaxine—Diarrhoea—Prednisone—systemic scleroderma	4.8e-05	0.000118	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.79e-05	0.000118	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—systemic scleroderma	4.66e-05	0.000115	CcSEcCtD
Venlafaxine—Dizziness—Prednisone—systemic scleroderma	4.64e-05	0.000114	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—systemic scleroderma	4.63e-05	0.000114	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—systemic scleroderma	4.63e-05	0.000114	CcSEcCtD
Venlafaxine—Vomiting—Prednisone—systemic scleroderma	4.46e-05	0.00011	CcSEcCtD
Venlafaxine—ABCB1—lung—systemic scleroderma	4.45e-05	0.0107	CbGeAlD
Venlafaxine—Rash—Prednisone—systemic scleroderma	4.42e-05	0.000109	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—systemic scleroderma	4.42e-05	0.000109	CcSEcCtD
Venlafaxine—Headache—Prednisone—systemic scleroderma	4.39e-05	0.000108	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—systemic scleroderma	4.32e-05	0.000107	CcSEcCtD
Venlafaxine—Asthenia—Methotrexate—systemic scleroderma	4.21e-05	0.000104	CcSEcCtD
Venlafaxine—Nausea—Prednisone—systemic scleroderma	4.17e-05	0.000103	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—systemic scleroderma	4.15e-05	0.000102	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—systemic scleroderma	4.01e-05	9.89e-05	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—systemic scleroderma	3.88e-05	9.56e-05	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—systemic scleroderma	3.73e-05	9.19e-05	CcSEcCtD
Venlafaxine—Rash—Methotrexate—systemic scleroderma	3.7e-05	9.11e-05	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—systemic scleroderma	3.69e-05	9.11e-05	CcSEcCtD
Venlafaxine—Headache—Methotrexate—systemic scleroderma	3.67e-05	9.06e-05	CcSEcCtD
Venlafaxine—Nausea—Methotrexate—systemic scleroderma	3.48e-05	8.59e-05	CcSEcCtD
